位置：成果数据库 > 期刊 > 期刊详情页
FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
  • ISSN号：1078-0432
  • 期刊名称：Clinical Cancer Research
  • 时间：2014.8.1
  • 页码：4107-4114
  • 相关项目：不吸烟肺腺癌患者突变谱研究和未知致癌突变的筛选鉴定
作者： 陈海泉|
同期刊论文项目
不吸烟肺腺癌患者突变谱研究和未知致癌突变的筛选鉴定
期刊论文 16
同项目期刊论文
ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and
RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.
ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion p
Oncogenic mutations are associated with histological subtypes but do not have an independent prognos
The pemetrexed-containing treatments in the non-small cell lung cancer is -/low thymidylate synthase
Recurrent TERT promoter mutations in non-small cell lung cancers.
Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas.
Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of
The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma.
A comprehensive investigation of molecular features and prognosis of lung adenocarcinoma with microp